...
机译:随机期二期试验的三年随访,与顺铂和培育蛋白与顺铂和血管素(治疗研究)进行了早期NSCLC辅助化学疗法
Heidelberg Univ Thoraxklin Pneumol Amalienstr 5 D-69126 Heidelberg Germany;
Univ Hosp KU Leuven Pneumol Dept Resp Oncol Unit Leuven Belgium;
Klin Loewenstein Oncol Dept Internal Med 2 Lowenstein Germany;
Univ Duisburg Essen Ruhrlandklin West German Canc Ctr Dept Med Oncol Univ Hosp Essen Essen;
Heidelberg Univ Thoraxklin Dept Thorac Surg Amalienstr 5 D-69126 Heidelberg Germany;
HELIOS Klinikum Emil von Behring Lungenklin Heckeshorn Dept Pneumol Berlin Germany;
Lungenklin Hemer Dept Pneumol 3 Hemer Germany;
Dr Horst Schmidt Kliniken GmbH Dept Hematol Oncol Wiesbaden Germany;
Airway Res Ctr North ARCN Lungen Clin Grosshansdorf Dept Thorac Oncol Grosshansdorf Germany;
Kliniken Stadt Koln Lungenklin Merheim Cologne Germany;
Univ Gottingen Dept Hematol &
Oncol D-37073 Gottingen Germany;
Ziekenhuis Oost Limburg Dept Resp Med Genk Belgium;
Univ Clin Ulm Dept Internal Med 2 Kempten Germany;
Univ Hosp Leuven Dept Thorac Surg Leuven Belgium;
Klin Loewenstein Dept Thorac Surg Loewenstein Germany;
Univ Duisburg Essen Univ Hosp Ruhrlandklin Essen Dept Thorac Surg Essen Germany;
Pius Hospital Oldenburg Dept Hematol &
Oncol Oldenburg Germany;
Heidelberg Univ Thoraxklin Thorac Oncol Amalienstr 5 D-69126 Heidelberg Germany;
Non-small cell lung cancer; Adjuvant chemotherapy; Pemetrexed; Outcome; Toxicity;
机译:随机期二期试验的三年随访,与顺铂和培育蛋白与顺铂和血管素(治疗研究)进行了早期NSCLC辅助化学疗法
机译:Gefitinib与vinorelbine Plus顺铂作为阶段II-IIIa(N1-N2)EGFR-突变体NSCLC(佐剂/ CTONG1104)的辅助处理:随机,开放标签,第3期研究
机译:在恶性胸膜间皮瘤的培美曲塞加顺铂与单纯顺铂三期试验的患者中接受二线(研究后)化疗。
机译:提炼早期非小细胞肺癌的试验。培美曲塞和顺铂与长春瑞滨和顺铂的辅助化疗:TREAT方案
机译:II期临床试验的三年随访随访,该试验改善了顺铂和培美曲塞与非铂和长春瑞滨对NSCLC早期辅助化疗的疗效(TREAT研究)